Waverly Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Waverly Advisors's LLY Position: Q1 2026 in Review
Waverly Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q1 2026, buying an estimated $3.28M and bringing the position to 61,378 shares worth $56.5M. The position accounts for 0.42% of the portfolio, ranked #51.
Waverly Advisors first reported a position in LLY in Q3 2013 and has held it in 25 quarters since. The position peaked at $62.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Waverly Advisors held 61,378 shares of Eli Lilly worth $56.5M as of Q1 2026.
- Waverly Advisors bought 3,240 Eli Lilly shares in Q1 2026, an estimated $3.28M.
- Eli Lilly made up 0.42% of Waverly Advisors's portfolio in Q1 2026, its #51 holding.
- Waverly Advisors first reported a position in Eli Lilly in Q3 2013 and has held it in 25 quarters since.
- Waverly Advisors's Eli Lilly position peaked at $62.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.